viral
diseas
like
influenza
aid
hepat
ebola
caus
sever
epidem
worldwid
along
resist
strain
new
pathogen
virus
continu
discov
creat
ongo
need
new
antivir
treatment
rna
interfer
cellular
genesilenc
phenomenon
sequencespecif
degrad
target
mrna
achiev
mean
complementari
short
interf
rna
sirna
molecul
short
interf
rna
technolog
afford
potenti
tractabl
strategi
combat
viral
pathogenesi
sirna
specif
easi
design
direct
multipl
strain
viru
target
conserv
gene
region
review
briefli
summar
current
statu
sirna
therapi
repres
exampl
differ
viru
famili
addit
aspect
like
design
deliveri
medic
signific
bioinformat
resourc
limit
also
discuss
high
mutat
rate
virus
potenti
elud
host
defens
system
well
antivir
drug
vaccin
thu
develop
new
altern
antivir
therapi
becom
import
past
decad
scientist
wide
use
cellular
rna
interfer
rnai
pathway
approach
target
number
viral
gene
restrain
express
pathway
long
doublestrand
rna
dsrna
precursor
split
short
interf
rna
sirna
follow
rnainduc
silenc
complex
includ
one
sirna
strand
slice
complementari
target
mrna
use
atp
short
interf
rna
technolog
exploit
target
diseasecaus
gene
well
function
studi
also
strategi
target
divers
type
virus
even
tini
viral
genom
provid
sever
target
region
exampl
sirna
direct
differ
gene
deadli
virus
like
human
immunodefici
viru
hiv
influenza
viru
infv
hepat
b
viru
hbv
sar
coronaviru
sarscov
human
papillomaviru
hpv
west
nile
viru
wnv
infect
cell
display
encourag
result
inhibit
viral
replic
research
also
use
multipl
sirna
simultan
augment
viral
inhibit
coordin
approach
short
interf
rna
variou
human
virus
like
respiratori
syncyti
viru
rsv
hepat
c
viru
hcv
hbv
hiv
also
appear
clinic
trial
elucid
import
inhibit
viral
infect
thu
sirna
emerg
practic
modular
adapt
therapeut
treat
viral
infect
review
discuss
use
sirna
differ
viral
famili
therapeut
applic
design
deliveri
consider
limit
sirna
antivir
remedi
measur
also
discuss
virus
tini
oblig
intracellular
parasit
either
rna
dna
genom
enclos
viruscod
protein
coat
virus
depend
host
cell
prolifer
classifi
account
shape
genom
structur
mode
replic
mani
class
pathogen
caus
larg
number
diseas
differ
organ
differ
speci
virus
vari
type
infect
process
howev
mani
gener
step
figur
short
interf
rna
direct
specif
viralhost
gene
block
viru
life
cycl
step
rnai
cellular
mechan
wherein
small
molecul
rna
hinder
express
particular
gene
via
counteract
correspond
mrna
molecul
possess
nucleotid
sequenc
complimentari
small
rna
histor
rnai
identifi
differ
term
quell
cosuppress
posttranscript
gene
silenc
mello
fire
illustr
strong
gene
silenc
caus
inject
dsrna
caenorhabd
elegan
find
field
rnai
pictori
summar
figur
rnai
pathway
process
dsrna
nucleotidelong
rna
molecul
act
modul
silenc
machineri
distinct
suppress
expressionfunct
intend
genegenom
region
figur
particular
silenc
pathway
involv
chop
dsrna
sirna
typic
base
pair
long
dsrna
dinucleotid
overhang
termini
one
sirna
strand
guid
strand
incorpor
rnainduc
silenc
complex
degrad
target
mrna
sirna
result
origin
longer
dsrna
differ
microrna
latter
gener
partial
base
pair
target
mrna
restrain
express
sever
differ
gene
relat
sequenc
short
interf
rna
also
differ
short
hairpin
rna
latter
hairpin
turn
express
cell
usual
achiev
mean
bacterialvir
vector
short
interf
rna
characterist
basepair
complet
caus
mrna
cleavag
precis
target
region
microrna
gener
intron
gene
gene
silenc
take
place
mrna
cleavag
thwart
mrna
translat
role
microrna
regul
gene
express
plant
kingdom
rnai
broadcast
transport
sirna
amid
cell
via
plasmodesmata
rnai
describ
breakthrough
year
rnai
also
believ
compon
primit
immun
system
base
nucleic
acid
recognit
show
harm
effect
control
cell
indic
meager
offtarget
effect
illustr
sirna
treatment
potenti
suppress
progress
cervic
cancer
polyomavirus
doublestrand
circular
dna
genom
repress
tag
oncogen
shown
hinder
transform
cell
short
interf
rna
design
target
bkv
tag
report
restrain
express
prpc
cell
line
block
tag
result
diminish
growth
rate
bkvtransform
cell
thu
suppress
tumorigen
poxvirus
singl
linear
doublestrand
dna
infect
vertebr
invertebr
vaccinia
viru
vacv
quintessenti
member
poxvirida
vacv
produc
dsrna
figur
timelin
depict
sequenti
progress
field
rna
interfer
rnai
shrna
short
hairpin
rna
sirna
short
interf
rna
rna
interfer
mechan
doublestrand
rna
dsrna
chop
short
nucleotid
interf
rna
sirna
molecul
possess
dinucleotid
overhang
termini
one
sirna
strand
integr
rnainduc
silenc
complex
risc
final
degrad
complementari
target
mrna
group
virus
contain
linear
singlestrand
positivesens
rna
one
member
chikungunya
viru
caus
agent
chikungunya
fever
emerg
import
arbovir
infect
public
health
concern
short
interf
rna
target
conserv
segment
mrna
pathogen
abl
drastic
reduc
viru
titer
vero
cell
sever
acut
respiratori
syndrom
also
known
sarscov
member
coronavirida
famili
whose
member
singl
zika
viru
recent
pose
global
health
threat
prompt
intens
research
control
pathogen
scientist
found
conserv
utr
viru
genom
play
crucial
function
replic
therefor
ration
design
sirna
utr
predict
inhibit
pathogen
studi
also
shown
sirnadirect
silenc
host
endoplasm
reticulum
membran
complex
protein
compon
halt
replic
multipl
zika
viru
strain
hela
cell
hepevirida
mainli
includ
hepat
e
viru
key
sourc
waterborn
hepat
adult
particularli
high
mortal
pregnant
women
short
interf
rna
develop
helicas
replicas
gene
hepat
e
viru
found
effect
inhibit
viru
replic
well
cell
retrovirida
famili
envelop
singlestrand
rna
virus
replic
host
cell
process
revers
transcript
note
sirna
inhibit
growth
aim
gene
host
cell
receptor
viral
gag
nef
protein
design
sirna
high
antivir
activ
challeng
task
mani
featur
influenc
sirna
efficaci
includ
gc
guaninecytosin
content
nucleotid
sirna
termini
thermodynam
properti
sirna
structur
access
target
site
also
sirna
develop
conserv
target
site
prevent
viral
escap
due
mutat
suggest
singl
target
site
might
enough
durabl
viral
silenc
use
multipl
sirna
sever
target
site
also
prevent
viral
escap
addit
chemic
modifi
nucleotid
also
use
enhanc
stabil
reduc
offtarget
effect
sirna
short
interf
rna
deliv
number
way
eg
encapsul
synthet
vehicl
cation
liposomesnanoparticl
sirna
conjug
cell
penetr
peptid
specif
antibodi
infect
cell
liposom
frequent
use
deliveri
medium
wide
rang
drug
includ
sirna
method
often
involv
cation
lipid
overcom
neg
charg
associ
sirna
late
stabl
nucleic
acid
lipid
particl
use
effici
stabil
transport
sirna
morrissey
et
al
use
stabl
nucleic
acid
lipid
particl
deliv
sirna
hbv
effici
inhibit
viru
mice
next
polymerbas
sirna
deliveri
vehicl
polyplex
afford
high
structur
physicochem
flexibl
shield
sirna
nucleas
likewis
inorgan
nanoparticl
gener
calcium
phosphat
gold
carbon
iron
oxid
sometim
prefer
transport
sirna
due
small
size
increas
permeabl
comparison
liposom
polyplex
occasion
surfac
ligand
incorpor
nanoparticl
enhanc
select
target
diseas
cell
plasmid
viral
vector
also
use
express
cassett
sustain
silenc
effect
howev
use
plasmid
limit
deliveri
effici
compar
viral
vector
altern
direct
inject
infect
tissu
may
also
help
target
specif
cell
although
larg
number
databas
design
predict
algo
reynold
et
al
uitei
et
al
amarzguioui
et
al
jagla
et
al
